J&J pauses vaccine production but SA unlikely to be affected
An article in the New York Times says Johnson & Johnson has temporarily halted production of the Covid-19 vaccine to pursue more lucrative ventures
15 February 2022 - 18:28
Johnson & Johnson (J&J) has temporarily paused production of its Covid-19 vaccine to pursue something more lucrative, but SA will not fall victim to the shortfall.
The pause in production, according to the New York Times, is a worry for much of the developing world as the J&J vaccine is their main supply in the fight against Covid-19...
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.